ArticleRenal failure2025

Proton pump inhibitor use and cardiovascular risk, all-cause, and cardiovascular mortality across baseline eGFR categories: a longitudinal study.

Tian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.